by Team Small News | Sep 21, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries Ltd, a prominent pharmaceutical company, has been instructed to limit the phase III study of Revefenacin to patients with Chronic Obstructive Pulmonary Disease (COPD) who are already receiving triple therapy. This decision comes as a...
by Team Small News | Sep 20, 2025 | Pharma, Sun Pharma
Sun Pharma, one of India’s largest pharmaceutical companies, has undergone a significant leadership transition. Dilip Shanghvi, the company’s founder and promoter, has transitioned to the role of executive chairman, while Kirti Ganorkar, who headed the...
by Team Small News | Sep 14, 2025 | Aurobindo Pharma, Biocon, Cipla, Glenmark, Lupin, Mankind, Pharma, Sun Pharma, Torrent Pharma, Zydus
The pharmaceutical industry is complex, with various segments such as innovator products, generics, branded generics, and API. Indian companies are making headway globally, and understanding the industry’s intricacies is crucial for those seeking opportunities....
by Team Small News | Sep 12, 2025 | Apollo Hospital, Pharma, Sun Pharma
The Indian healthcare sector has experienced a significant surge in profit, with a 29% rise in profit after tax (PAT) in the fiscal year 2025. This makes it the second-fastest growing sector in the country, surpassed only by the non-ferrous metals sector. The...
by Team Small News | Sep 10, 2025 | Pharma, Sun Pharma
The US Food and Drug Administration (FDA) has flagged Sun Pharma’s Halol plant in India with an “Official Action Indicated” (OAI) status. This decision comes after the plant was found to have repeated safety breaches. The OAI status is a serious...
by Team Small News | Sep 8, 2025 | Cipla, Lupin, Mankind, Pharma, Sun Pharma
The Indian pharmaceutical companies, Sun Pharma and Lupin, are developing oral semaglutide pills to address obesity and injection aversion. Currently, leading anti-obesity drugs like Mounjaro and Wegovy are available in injectable form, limiting accessibility and...